What's Driving M&A?

With the need for increased pricing power and scale due to the inflationary carnage of 2022–2023, healthcare M&A activity is poised to accelerate. For the first time since immediately following the Balanced Budget Act of 1997, which curtailed governmental reimbursement, significant numbers of providers lost money on an operating basis.

Many providers, driven by inflationary pressure on labor, which included unprecedented contract labor cost, experienced double digit percentage growth in operating expenses. To make matters more challenging, providers were not able to offset operational weakness with investment portfolio returns given the decline in debt and equity markets during this period.

In the latest HealthLeaders Intelligence Report, learn more about how healthcare leaders envision the current and future state of M&A, including focuses on:
  • The impact that economic uncertainty is having on M&A plans
  • How the regulatory climate is affecting M&A
  • Estimates on the future of M&A
  • And more!

Download the whitepaper to learn more! 

Sponsored by